p66Shc adaptor protein is a newly recognized mediator of mitochondrial dysfunction.
Expression of p66Shc was significantly increased in human airway epithelial cells with CSE exposure.
The high expression of p66Shc induced excess of intracellular ROS production and mitochondria dysfunction.
Excessive ROS triggers the inflammatory response and mucus hypersecretion in part by activating NF-κB signaling and inhibiting FoxO3a activity.
Manipulating p66Shc might offer a new therapeutic modality with which to treat chronic inflammatory airway diseases.